Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

Letrozole 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer × Aromatase Inhibitors × Clear all
NCT05190094 2025-05-07

ICRG0201

International Cancer Research Group, United Arab Emirates

Phase 2 Recruiting
80 enrolled
Breast

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡